Metatron Health

Botanical species · safety record

Piper kadsura

The EFSA Compendium of Botanicals holds 4 constituent measurements for Piper kadsura. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Piper kadsura (Choisy) Ohwi

4Constituent measurements
0Safety records
3Cited sources
31Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 31 licensed products naming Piper kadsura as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Stem
  • Stem(s)

What the records describe

Constituents measured

  • Neolignans2
  • Kadsurenone1
  • Lignans, total1

Plant parts

  • Aerial part of plants2
  • Stem2
  • stalk2

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
KadsurenoneStem / stalkSolvent extraction0.288 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Lignans, totalStem / stalkSolvent extraction0.395 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
NeolignansAerial part of plantsSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
NeolignansAerial part of plants——Colorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kim, Ki Hyun., Choi, Jung Wook., Ha, Sang Keun., Kim, Sun Yeou., Lee, Kang Ro. Neolignans from Piper kadsura and their anti-neuroinflammatory activity. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, vol. 20, no. 1, p. 409-412. DOI
  2. Cai, Cheng-Cheng., Yan, Ma-Cheng., Xie, Hui., Pan, Sheng-Li. Simultaneous Determination of Ten Active Components in 12 Chinese Piper Species by HPLC. AMERICAN JOURNAL OF CHINESE MEDICINE, 2011, vol. 39, no. 5, p. 1043-1060. DOI
  3. Jiang, RW., Mak, TCW., Fung, KP. Molecular structures of two bicyclo-(3.2.1)-octanoid neolignans from Piper kadsura. JOURNAL OF MOLECULAR STRUCTURE, 2003, vol. 654, no. 1-3, p. 177-182. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.